by Zhao, Yiming, Fay, Francois, Hak, Sjoerd, Perez-Aguilar, Jose Manuel, Sanchez-Gaytan, Brenda L, Goode, Brandon, Duivenvoorden, Raphaël, de Lange Davies, Catharina, Bjørkøy, Astrid, Weinstein, Harel, Fayad, Zahi A, Pérez-Medina, Carlos and Mulder, Willem J M
Abstract:
A major goal of cancer nanotherapy is to use nanoparticles as carriers for targeted delivery of anti-tumour agents. The drugtextendashcarrier association after intravenous administration is essential for efficient drug delivery to the tumour. However, …
Reference:
Augmenting drugtextendashcarrier compatibility improves tumour nanotherapy efficacy (Zhao, Yiming, Fay, Francois, Hak, Sjoerd, Perez-Aguilar, Jose Manuel, Sanchez-Gaytan, Brenda L, Goode, Brandon, Duivenvoorden, Raphaël, de Lange Davies, Catharina, Bjørkøy, Astrid, Weinstein, Harel, Fayad, Zahi A, Pérez-Medina, Carlos and Mulder, Willem J M), In Nature Communications, Nature Publishing Group, volume 7, 2016.
Bibtex Entry:
@article{Zhao:2016ct,
author = {Zhao, Yiming and Fay, Francois and Hak, Sjoerd and Perez-Aguilar, Jose Manuel and Sanchez-Gaytan, Brenda L and Goode, Brandon and Duivenvoorden, Rapha{"e}l and de Lange Davies, Catharina and Bj{o}rk{o}y, Astrid and Weinstein, Harel and Fayad, Zahi A and P{'e}rez-Medina, Carlos and Mulder, Willem J M},
title = {{Augmenting drug{textendash}carrier compatibility improves tumour nanotherapy efficacy}},
journal = {Nature Communications},
year = {2016},
volume = {7},
pages = {11221},
publisher = {Nature Publishing Group},
affiliation = {Translational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, USA.},
doi = {10.1038/ncomms11221},
pmid = {27071376},
pmcid = {PMC4833858},
language = {English},
rating = {0},
date-added = {2017-08-22T11:03:11GMT},
date-modified = {2020-07-09T13:27:48GMT},
abstract = {A major goal of cancer nanotherapy is to use nanoparticles as carriers for targeted delivery of anti-tumour agents. The drug{textendash}carrier association after intravenous administration is essential for efficient drug delivery to the tumour. However, ...},
url = {http://www.nature.com/doifinder/10.1038/ncomms11221},
uri = {url{papers3://publication/doi/10.1038/ncomms11221}}
}